Literature DB >> 8677772

A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage.

A N de Groot1, J van Roosmalen, P W van Dongen, G F Borm.   

Abstract

BACKGROUND: Active management with oral ergometrine 0.4 mg was compared with expectant management for the control of blood loss in the third stage of labor in women at low risk of postpartum hemorrhage (PPH).
METHODS: A three-arms randomized trial in which 0.4 mg ergometrine (2 tablets of 0.2 mg) was set off against placebo, both groups allowing comparison with a standard oxytocin regimen of 5 IU. Women at low risk for PPH. Of 367 parturients, 146 were randomised to ergometrine 0.4 mg, 143 to placebo and 78 to intramuscular oxytocin in a 2:2:1 design.
RESULTS: Compared with placebo, ergometrine reduced blood loss with 5% (-5%; Confidence interval: -20% to +13%). Oxytocin reduced blood loss with 9% (-9%; Confidence interval: -26% to +12%) versus placebo.
CONCLUSION: Oral ergometrine has too little effect on blood loss after childbirth in order to be a good alternative to parenteral prophylactic management.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8677772     DOI: 10.3109/00016349609033355

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  10 in total

Review 1.  Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage.

Authors:  Christina S Chu; Petra Brhlikova; Allyson M Pollock
Journal:  J R Soc Med       Date:  2012-08       Impact factor: 5.344

Review 2.  What measured blood loss tells us about postpartum bleeding: a systematic review.

Authors:  N L Sloan; J Durocher; T Aldrich; J Blum; B Winikoff
Journal:  BJOG       Date:  2010-04-20       Impact factor: 6.531

3.  Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.

Authors:  Jennifer A Salati; Sebastian J Leathersich; Myfanwy J Williams; Anna Cuthbert; Jorge E Tolosa
Journal:  Cochrane Database Syst Rev       Date:  2019-04-29

4.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Argyro Papadopoulou; Rebecca Man; Nikolaos Athanasopoulos; Aurelio Tobias; Malcolm J Price; Myfanwy J Williams; Virginia Diaz; Julia Pasquale; Monica Chamillard; Mariana Widmer; Özge Tunçalp; G Justus Hofmeyr; Fernando Althabe; Ahmet Metin Gülmezoglu; Joshua P Vogel; Olufemi T Oladapo; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

Review 5.  Prophylactic use of ergot alkaloids in the third stage of labour.

Authors:  Tippawan Liabsuetrakul; Thanapan Choobun; Krantarat Peeyananjarassri; Q Monir Islam
Journal:  Cochrane Database Syst Rev       Date:  2018-06-07

6.  Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis.

Authors:  Lydia Hawker; Andrew Weeks
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-13       Impact factor: 3.007

7.  Management of third stage of labor with misoprostol: A comparison of three routes of administration.

Authors:  Sukhwinder Kaur Bajwa; Sukhminder Jit Singh Bajwa; Harpreet Kaur; S P S Goraya; Anita Singh; Harpreet Kaurishar
Journal:  Perspect Clin Res       Date:  2012-07

Review 8.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25

9.  Active management of the third stage of labour without controlled cord traction: a randomized non-inferiority controlled trial.

Authors:  A Metin Gülmezoglu; Mariana Widmer; Mario Merialdi; Zahida Qureshi; Gilda Piaggio; Diana Elbourne; Hany Abdel-Aleem; Guillermo Carroli; G Justus Hofmeyr; Pisake Lumbiganon; Richard Derman; Pius Okong; Shivaprasad Goudar; Mario Festin; Fernando Althabe; Deborah Armbruster
Journal:  Reprod Health       Date:  2009-01-21       Impact factor: 3.223

10.  New Evidence on Carbetocin: Another Arrow in Our Quiver.

Authors:  Steve Hodgins
Journal:  Glob Health Sci Pract       Date:  2018-10-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.